Reviews7 August 2012
A Systematic Review and Meta-analysis
    Author, Article, and Disclosure Information

    Abstract

    Background:

    Viscosupplementation, the intra-articular injection of hyaluronic acid, is widely used for symptomatic knee osteoarthritis.

    Purpose:

    To assess the benefits and risks of viscosupplementation for adults with symptomatic knee osteoarthritis.

    Data Sources:

    MEDLINE (1966 to January 2012), EMBASE (1980 to January 2012), the Cochrane Central Register of Controlled Trials (1970 to January 2012), and other sources.

    Study Selection:

    Randomized trials in any language that compared viscosupplementation with sham or nonintervention control in adults with knee osteoarthritis.

    Data Extraction:

    Primary outcomes were pain intensity and flare-ups. Secondary outcomes included function and serious adverse events. Reviewers used duplicate abstractions, assessed study quality, pooled data by using a random-effects model, examined funnel plots, and explored heterogeneity by using meta-regression.

    Data Synthesis:

    Eighty-nine trials involving 12 667 adults met inclusion criteria. Sixty-eight had a sham control, 40 had a follow-up duration greater than 3 months, and 22 used cross-linked forms of hyaluronic acid. Overall, 71 trials (9617 patients) showed that viscosupplementation moderately reduced pain (effect size, −0.37 [95% CI, −0.46 to −0.28]). There was important between-trial heterogeneity and an asymmetrical funnel plot: Trial size, blinded outcome assessment, and publication status were associated with effect size. Five unpublished trials (1149 patients) showed an effect size of −0.03 (CI, −0.14 to 0.09). Eighteen large trials with blinded outcome assessment (5094 patients) showed a clinically irrelevant effect size of −0.11 (CI, −0.18 to −0.04). Six trials (811 patients) showed that viscosupplementation increased, although not statistically significantly, the risk for flare-ups (relative risk, 1.51 [CI, 0.84 to 2.72]). Fourteen trials (3667 patients) showed that viscosupplementation increased the risk for serious adverse events (relative risk, 1.41 [CI, 1.02 to 1.97]).

    Limitations:

    Trial quality was generally low. Safety data were often not reported.

    Conclusion:

    In patients with knee osteoarthritis, viscosupplementation is associated with a small and clinically irrelevant benefit and an increased risk for serious adverse events.

    Primary Funding Source:

    Arco Foundation.

    References

    • 1. Murray CJL, Lopez AD, eds. The Global Burden of Disease: A Comprehensive Assessment of Mortality and Disability from Diseases, Injuries, and Risk Factors in 1990 and Projected to 2020. Cambridge: Harvard School of Public Health, on behalf of the World Health Organization; 1996. (Global Burden of Disease and Injury Series, Vol. 1). Google Scholar
    • 2. Smalley WERay WADaugherty JRGriffin MRNonsteroidal anti-inflammatory drugs and the incidence of hospitalizations for peptic ulcer disease in elderly persons. Am J Epidemiol1995;141:539-45. [PMID: 7900721] CrossrefMedlineGoogle Scholar
    • 3. Trelle SReichenbach SWandel SHildebrand PTschannen BVilliger PMet alCardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis. BMJ2011;342:c7086. [PMID: 21224324] CrossrefMedlineGoogle Scholar
    • 4. Brandt KDSmith GNSimon LSIntraarticular injection of hyaluronan as treatment for knee osteoarthritis: what is the evidence? Arthritis Rheum2000;43:1192-203. [PMID: 10857778] CrossrefMedlineGoogle Scholar
    • 5. Balazs EADenlinger JLViscosupplementation: a new concept in the treatment of osteoarthritis. J Rheumatol Suppl1993;39:3-9. [PMID: 8410881] MedlineGoogle Scholar
    • 6. Campbell JBellamy NGee TDifferences between systematic reviews/meta-analyses of hyaluronic acid/hyaluronan/hylan in osteoarthritis of the knee. Osteoarthritis Cartilage2007;15:1424-36. [PMID: 17448701] CrossrefMedlineGoogle Scholar
    • 7. Rutjes AWNüesch ESterchi RKalichman LHendriks EOsiri Met alTranscutaneous electrostimulation for osteoarthritis of the knee. Cochrane Database Syst Rev2009;:CD002823. [PMID: 19821296] MedlineGoogle Scholar
    • 8. Altman RBrandt KHochberg MMoskowitz RBellamy NBloch DAet alDesign and conduct of clinical trials in patients with osteoarthritis: recommendations from a task force of the Osteoarthritis Research Society. Results from a workshop. Osteoarthritis Cartilage1996;4:217-43. [PMID: 11048620] CrossrefMedlineGoogle Scholar
    • 9. Pham Tvan der Heijde DAltman RDAnderson JJBellamy NHochberg Met alOMERACT-OARSI initiative: Osteoarthritis Research Society International set of responder criteria for osteoarthritis clinical trials revisited. Osteoarthritis Cartilage2004;12:389-99. [PMID: 15094138] CrossrefMedlineGoogle Scholar
    • 10. Jüni PReichenbach SDieppe POsteoarthritis: rational approach to treating the individual. Best Pract Res Clin Rheumatol2006;20:721-40. [PMID: 16979535] CrossrefMedlineGoogle Scholar
    • 11. Reichenbach SSterchi RScherer MTrelle SBürgi EBürgi Uet alMeta-analysis: chondroitin for osteoarthritis of the knee or hip. Ann Intern Med2007;146:580-90. [PMID: 17438317] LinkGoogle Scholar
    • 12. Reichenbach SBlank SRutjes AWShang AKing EADieppe PAet alHylan versus hyaluronic acid for osteoarthritis of the knee: a systematic review and meta-analysis. Arthritis Rheum2007;57:1410-8. [PMID: 18050181] CrossrefMedlineGoogle Scholar
    • 13. European Commission. Guidelines on Medical Devices. Clinical Investigations: Serious Adverse Event Reporting Under Directives 90/385/EEC and 93/42/EEC. Brussels, Belgium: European Commission; 2010. Accessed at http://ec.europa.eu/health/medical-devices/files/meddev/2_7_3_en.pdf on 27 February 2012. Google Scholar
    • 14. Higgins JPT, Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions, version 5.1.0 [updated March 2011]. Oxford, UK: The Cochrane Collaboration; 2011. Accessed at www.cochrane-handbook.org on 21 May 2012. Google Scholar
    • 15. Jüni PAltman DGEgger MSystematic reviews in health care: Assessing the quality of controlled clinical trials. BMJ2001;323:42-6. [PMID: 11440947] CrossrefMedlineGoogle Scholar
    • 16. Wandel SJüni PTendal BNüesch EVilliger PMWelton NJet alEffects of glucosamine, chondroitin, or placebo in patients with osteoarthritis of hip or knee: network meta-analysis. BMJ2010;341:c4675. [PMID: 20847017] CrossrefMedlineGoogle Scholar
    • 17. Angst FAeschlimann AMichel BAStucki GMinimal clinically important rehabilitation effects in patients with osteoarthritis of the lower extremities. J Rheumatol2002;29:131-8. [PMID: 11824949] MedlineGoogle Scholar
    • 18. Angst FAeschlimann AStucki GSmallest detectable and minimal clinically important differences of rehabilitation intervention with their implications for required sample sizes using WOMAC and SF-36 quality of life measurement instruments in patients with osteoarthritis of the lower extremities. Arthritis Rheum2001;45:384-91. [PMID: 11501727] MedlineGoogle Scholar
    • 19. Eberle EOttillinger BClinically relevant change and clinically relevant difference in knee osteoarthritis. Osteoarthritis Cartilage1999;7:502-3. [PMID: 10489324] CrossrefMedlineGoogle Scholar
    • 20. Salaffi FStancati ASilvestri CACiapetti AGrassi WMinimal clinically important changes in chronic musculoskeletal pain intensity measured on a numerical rating scale. Eur J Pain2004;8:283-91. [PMID: 15207508] CrossrefMedlineGoogle Scholar
    • 21. DerSimonian RLaird NMeta-analysis in clinical trials. Control Clin Trials1986;7:177-88. [PMID: 3802833] CrossrefMedlineGoogle Scholar
    • 22. Spiegelhalter DJAbrams KRMyles JPBayesian Approaches to Clinical Trials and Health-Care Evaluation. Chichester, UK: J Wiley; 2004. Google Scholar
    • 23. Sterne JAEgger MFunnel plots for detecting bias in meta-analysis: guidelines on choice of axis. J Clin Epidemiol2001;54:1046-55. [PMID: 11576817] CrossrefMedlineGoogle Scholar
    • 24. Moreno SGSutton AJTurner EHAbrams KRCooper NJPalmer TMet alNovel methods to deal with publication biases: secondary analysis of antidepressant trials in the FDA trial registry database and related journal publications. BMJ2009;339:b2981. [PMID: 19666685] CrossrefMedlineGoogle Scholar
    • 25. Peters JLSutton AJJones DRAbrams KRRushton LContour-enhanced meta-analysis funnel plots help distinguish publication bias from other causes of asymmetry. J Clin Epidemiol2008;61:991-6. [PMID: 18538991] CrossrefMedlineGoogle Scholar
    • 26. Palmer TMPeters JLSutton AJMoreno SGContour-enhanced funnel plots for meta-analysis. Stata J2008;8:242-54. CrossrefGoogle Scholar
    • 27. Shang AHuwiler-Müntener KNartey LJüni PDörig SSterne JAet alAre the clinical effects of homoeopathy placebo effects? Comparative study of placebo-controlled trials of homoeopathy and allopathy. Lancet2005;366:726-32. [PMID: 16125589] CrossrefMedlineGoogle Scholar
    • 28. Nüesch ETrelle SReichenbach SRutjes AWTschannen BAltman DGet alSmall study effects in meta-analyses of osteoarthritis trials: meta-epidemiological study. BMJ2010;341:c3515. [PMID: 20639294] CrossrefMedlineGoogle Scholar
    • 29. Egger MDavey Smith GSchneider MMinder CBias in meta-analysis detected by a simple, graphical test. BMJ1997;315:629-34. [PMID: 9310563] CrossrefMedlineGoogle Scholar
    • 30. Thompson SGSharp SJExplaining heterogeneity in meta-analysis: a comparison of methods. Stat Med1999;18:2693-708. [PMID: 10521860] CrossrefMedlineGoogle Scholar
    • 31. Royston PSauerbrei WA new approach to modelling interactions between treatment and continuous covariates in clinical trials by using fractional polynomials. Stat Med2004;23:2509-25. [PMID: 15287081] CrossrefMedlineGoogle Scholar
    • 32. Anika TherapeuticsConfidentially obtained report. Bedford, MA: Anika Therapeutics; 2000. Google Scholar
    • 33. Anika TherapeuticsConfidentially obtained report. Bedford, MA: Anika Therapeutics; 2001. Google Scholar
    • 34. Genzyme BiomaterialsConfidentially obtained report. Cambridge, MA: Genzyme Biomaterials; 2005. Google Scholar
    • 35. Personal communication (Rydell, 1972) described in: Peyron JG, Balazs EA. Preliminary clinical assessment of Na-hyaluronate injection into human arthritic joints. Pathol Biol (Paris)1974;22:731-6. [PMID: 4614175] MedlineGoogle Scholar
    • 36. Weiss CBalazs EASt Onge RDenlinger JLClinical studies of the intra-articular injections of Healon (sodium hyaluronate) in the treatment of osteoarthritis of human knees. Semin Arthritis Rheum1981;11 Suppl 1 143-4. CrossrefGoogle Scholar
    • 37. Shichikawa KIgarashi MSugawara SIwasaki YClinical evaluation of high molecular weight sodium hyaluronate (SPH) on osteoarthritis of the knee—a multi-center well controlled comparative study. Jpn J Clin Pharmacol Therapeut1983;14:545-58. CrossrefGoogle Scholar
    • 38. Shichikawa KMaeda AOgawa N[Clinical evaluation of sodium hyaluronate in the treatment of osteoarthritis of the knee]. Ryumachi1983;23:280-90. [PMID: 6364389] MedlineGoogle Scholar
    • 39. Bragantini ACassini Mde Bastiani GPerbellini AControlled single-blind trial of intra-articularly injected hyaluronic acid (Hyalgan) in osteo-arthritis of the knee. Clin Trials J1987;24:333-40. Google Scholar
    • 40. Grecomoro GMartorana UDi Marco CIntra-articular treatment with sodium hyaluronate in gonarthrosis: a controlled clinical trial versus placebo. Pharmatherapeutica1987;5:137-41. [PMID: 3310017] MedlineGoogle Scholar
    • 41. Dixon ASJacoby RKBerry HHamilton EBClinical trial of intra-articular injection of sodium hyaluronate in patients with osteoarthritis of the knee. Curr Med Res Opin1988;11:205-13. [PMID: 3063436] CrossrefMedlineGoogle Scholar
    • 42. Ghirardini MBetelemme LFatti FImpiego intraarticolare di acido ialuronico estrattivo de orgoteina sia separatamente che in associazione in pazienti affetti da gonartrosi in fase sinovitica [Abstract]. Reumatismo1990;42:132. Google Scholar
    • 43. Russell IJMichalek JELawrence VALessard JABriggs BTMay GSA randomized, placebo (PL) and no-intervention (NI) controlled, trial of intra-articular (IA) 1% sodium hyaluronate (HA) in the treatment of knee osteoarthritis (OA) [Abstract B94]. Arthritis Rheum1992;35 Suppl S132. Google Scholar
    • 44. Dougados MNguyen MListrat VAmor BHigh molecular weight sodium hyaluronate (hyalectin) in osteoarthritis of the knee: a 1 year placebo-controlled trial. Osteoarthritis Cartilage1993;1:97-103. [PMID: 8886085] CrossrefMedlineGoogle Scholar
    • 45. Isdale AHHordon LDBird HAWright VA controlled comparison of intra-articular Healon (hyaluronate), triamcinolone and saline in osteoarthritis of the knee [Abstract 118]. Br J Rheumatol1993;32 Suppl 1 61. Google Scholar
    • 46. Moreland LWArnold WJSaway ASavory CSikes DEfficacy and safety of intra-articular hylan G-F 20 (Synvisc), a viscoelastic derivative of hyaluronan, in patients with osteoarthritis of the knee [Abstract]. Arthritis Rheum1993;36 Suppl 9 165. Google Scholar
    • 47. Pedersen PBIntra-articular hyaluronic acid (HA) in the treatment of osteoarthritis (OA) of the knee [Abstract]. Osteoarthritis Cartilage1993;1:70. CrossrefGoogle Scholar
    • 48. Puhl WBernau AGreiling HKöpcke WPförringer WSteck KJet alIntra-articular sodium hyaluronate in osteoarthritis of the knee: a multicenter, double-blind study. Osteoarthritis Cartilage1993;1:233-41. [PMID: 15449510] CrossrefMedlineGoogle Scholar
    • 49. Cohen MAShiroky JBBallachey MLNeville CEsdaile JMDouble-blind randomized trial of intra-articular (I/A) hyaluronate in the treatment of osteoarthritis of the knee [Abstract 62]. Arthritis Rheum1994;37 Suppl 6 R31. Google Scholar
    • 50. Creamer PSharif MGeorge EMeadows KCushnaghan JShinmei Met alIntra-articular hyaluronic acid in osteoarthritis of the knee: an investigation into mechanisms of action. Osteoarthritis Cartilage1994;2:133-40. [PMID: 11548229] CrossrefMedlineGoogle Scholar
    • 51. Henderson EBSmith ECPegley FBlake DRIntra-articular injections of 750 kD hyaluronan in the treatment of osteoarthritis: a randomised single centre double-blind placebo-controlled trial of 91 patients demonstrating lack of efficacy. Ann Rheum Dis1994;53:529-34. [PMID: 7944639] CrossrefMedlineGoogle Scholar
    • 52. Scale DWobig MWolpert WViscosupplementation of osteoarthritic knees with hylan: a treatment schedule study. Curr Ther Res Clin Exp1994;55:220-32. CrossrefGoogle Scholar
    • 53. Adams MEAtkinson MHLussier AJSchulz JISiminovitch KAWade JPet alThe role of viscosupplementation with hylan G-F 20 (Synvisc) in the treatment of osteoarthritis of the knee: a Canadian multicenter trial comparing hylan G-F 20 alone, hylan G-F 20 with non-steroidal anti-inflammatory drugs (NSAIDs) and NSAIDs alone. Osteoarthritis Cartilage1995;3:213-25. [PMID: 8689457] CrossrefMedlineGoogle Scholar
    • 54. Carrabba MParesce EAngelini MRe KATorchiana EEMPerbellini AThe safety and efficacy of different dose schedules of hyaluronic acid in the treatment of painful osteoarthritis of the knee with joint effusion. Eur J Rheumatol Inflamm1995;15:25-31. Google Scholar
    • 55. Corrado EMPeluso GFGigliotti SDe DCPalmieri DSavoia Net alThe effects of intra-articular administration of hyaluronic acid on osteoarthritis of the knee: a clinical study with immunological and biochemical evaluations. Eur J Rheumatol Inflamm1995;15:47-56. Google Scholar
    • 56. Formiguera Sala SEsteve de Miguel RIntra-articular hyaluronic acid in the treatment osteoarthritis of the knee: a short term study. Eur J Rheumatol Inflamm1995;15:33-8. Google Scholar
    • 57. Guler M, Kuran B, Parlar D, Guler M, Saglam H, Yapici S, et al. Clinical trial of intra-articular injection of hyaluronic acid in patients with osteoarthritis of the knee [Abstract]. Presented at X National Rheumatology Congress, Pamukkale-Denizli, Turkey, 29 October–3 November 1996. Google Scholar
    • 58. Lohmander LSDalén NEnglund GHämäläinen MJensen EMKarlsson Ket alIntra-articular hyaluronan injections in the treatment of osteoarthritis of the knee: a randomised, double blind, placebo controlled multicentre trial. Hyaluronan Multicentre Trial Group. Ann Rheum Dis1996;55:424-31. [PMID: 8774159] CrossrefMedlineGoogle Scholar
    • 59. Graf von der Schulenburg JMAllhoff PGCost-effectiveness and quality of life of treatment of gonarthrosis with hyaluronic acid [Abstract 187]. Rheumatol Eur1997;26 Suppl 2 191. Google Scholar
    • 60. Kalay SThe effectiveness of intra-articular hyaluronic acid treatment in primary gonarthrosis [Specialization thesis]. Ankara, Turkey: Ministry of Health, Republic of Turkey; 1997. Google Scholar
    • 61. Listrat VAyral XPatarnello FBonvarlet JPSimonnet JAmor Bet alArthroscopic evaluation of potential structure modifying activity of hyaluronan (Hyalgan) in osteoarthritis of the knee. Osteoarthritis Cartilage1997;5:153-60. [PMID: 9219678] CrossrefMedlineGoogle Scholar
    • 62. Schneider UMiltner OGraf JThomsen MNiethard FU[Mechanism of action of hyaluronic acid in gonarthrosis of both knee joints in a right/left comparison. Study with dynamometry, oxygen partial pressure, temperature and Lequesne score]. Z Orthop Ihre Grenzgeb1997;135:341-7. [PMID: 9381772] CrossrefMedlineGoogle Scholar
    • 63. Wu JJShih LYHsu HCChen THThe double-blind test of sodium hyaluronate (ARTZ) on osteoarthritis knee. Zhonghua Yi Xue Za Zhi (Taipei)1997;59:99-106. [PMID: 9175299] MedlineGoogle Scholar
    • 64. Altman RDMoskowitz RIntraarticular sodium hyaluronate (Hyalgan) in the treatment of patients with osteoarthritis of the knee: a randomized clinical trial. Hyalgan Study Group. J Rheumatol1998;25:2203-12. [PMID: 9818665] MedlineGoogle Scholar
    • 65. Wobig MDickhut AMaier RVetter GViscosupplementation with hylan G-F 20: a 26-week controlled trial of efficacy and safety in the osteoarthritic knee. Clin Ther1998;20:410-23. [PMID: 9663358] CrossrefMedlineGoogle Scholar
    • 66. Huskisson ECDonnelly SHyaluronic acid in the treatment of osteoarthritis of the knee. Rheumatology (Oxford)1999;38:602-7. [PMID: 10461471] CrossrefMedlineGoogle Scholar
    • 67. Payne MWPetrella RJViscosupplementation effect on proprioception in the osteoarthritic knee. Arch Phys Med Rehabil2000;81:598-603. [PMID: 10807098] CrossrefMedlineGoogle Scholar
    • 68. Renklitepe NAtalay EThe effect of intra-articular sodium hyaluronate therapy in knee osteoarthritis [Abstract 328]. Ann Rheum Dis2000;59 Suppl 142. Google Scholar
    • 69. Ardiç FBolulu DTopuz OCubukçu SEfficacy of intra-articular hyaluronic acid injections in knee osteoarthritis [Abstract 75]. Ann Rheum Dis2001;60 Suppl 1 232. Google Scholar
    • 70. Bunyaratavej NChan KMSubramanian NTreatment of painful osteoarthritis of the knee with hyaluronic acid. Results of a multicenter Asian study. J Med Assoc Thai2001;84 Suppl 2 S576-81. [PMID: 11853284] MedlineGoogle Scholar
    • 71. Caracuel MAMuñoz-Villanueva MCEscudero AVeroz RFrias GVacas Jet alEffects of joint lavage and hyaluronic acid infiltration in patients with osteoarthritis of the knee [Abstract 91]. Ann Rheum Dis2001;60 Suppl 236. Google Scholar
    • 72. Dickson DJHosie GEnglish JRPrimary Care Rheumatology Society OA Knee Study GroupA double-blind, placebo-controlled comparison of hylan G-F 20 against diclofenac in knee osteoarthritis. J Clin Research2001;4:41-52. Google Scholar
    • 73. Groppa LGMoshneaga MStudying of the efficiency of the synvisk in osteoartrosis [Abstract 144]. Ann Rheum Dis2001;60 Suppl 1 230. Google Scholar
    • 74. Seikagaku Corporation. Summary of safety and effectiveness data: Sodium hyaluronate. Bethesda, MD: U.S. Food and Drug Administration; 2001. Accessed at www.accessdata.fda.gov/cdrh_docs/pdf/P980044b.pdf on 27 February 2012. Google Scholar
    • 75. Tamir ERobinson DKoren RAgar GHalperin NIntra-articular hyaluronan injections for the treatment of osteoarthritis of the knee: a randomized, double blind, placebo controlled study. Clin Exp Rheumatol2001;19:265-70. [PMID: 11407078] MedlineGoogle Scholar
    • 76. Bütün BKaçar CEvcik DIntra-articular injection of sodium hyaluronate in the treatment of knee osteoarthritis. Romatizma2002;17:31-8. Google Scholar
    • 77. Cogalgil S, Hatipoglu F. The effects of intra-articular sodium-hyaluronan in patients with gonarthrosis treated with physical therapy [Abstract 282]. Presented at the European League Against Rheumatism, 3rd Annual European Congress of Rheumatology, Stockholm, Sweden, 12–15 June 2002. Accessed at www.abstracts2view.com/eular/view.php?nu=EULAR2L1_2002AB0282&terms= on 21 May 2012. Google Scholar
    • 78. Hizmetli S, Kocagil S, Kaptanoglu E, Elden H, Nacitarhan V. The efficacy and safety of intra-articular hyaluronic acid in osteoarthritis of the knee: a prospective, double-blind trial. Pamphlet provided at the European League Against Rheumatism, 3rd Annual European Congress of Rheumatology, Stockholm, Sweden, 12–15 June 2002. Google Scholar
    • 79. Karlsson JSjögren LSLohmander LSComparison of two hyaluronan drugs and placebo in patients with knee osteoarthritis. A controlled, randomized, double-blind, parallel-design multicentre study. Rheumatology (Oxford)2002;41:1240-8. [PMID: 12421996] CrossrefMedlineGoogle Scholar
    • 80. Miltner OSchneider USiebert CHNiedhart CNiethard FUEfficacy of intraarticular hyaluronic acid in patients with osteoarthritis—a prospective clinical trial. Osteoarthritis Cartilage2002;10:680-6. [PMID: 12202120] CrossrefMedlineGoogle Scholar
    • 81. Petrella RJDiSilvestro MDHildebrand CEffects of hyaluronate sodium on pain and physical functioning in osteoarthritis of the knee: a randomized, double-blind, placebo-controlled clinical trial. Arch Intern Med2002;162:292-8. [PMID: 11822921] CrossrefMedlineGoogle Scholar
    • 82. Raynauld JPTorrance GWBand PAGoldsmith CHTugwell PWalker Vet alCanadian Knee OA Study GroupA prospective, randomized, pragmatic, health outcomes trial evaluating the incorporation of hylan G-F 20 into the treatment paradigm for patients with knee osteoarthritis (Part 1 of 2): clinical results. Osteoarthritis Cartilage2002;10:506-17. [PMID: 12127830] CrossrefMedlineGoogle Scholar
    • 83. Saravanan VMorgan TStobbs DDaymond TJInflammatory effusion after viscosupplementation with Hylan G-F 20 [Abstract 336]. Rheumatology2002;41 Suppl 1 121. MedlineGoogle Scholar
    • 84. Bayramoğlu MKarataş MCetin NAkman NSözay SDilek AComparison of two different viscosupplements in knee osteoarthritis—a pilot study. Clin Rheumatol2003;22:118-22. [PMID: 12740676] CrossrefMedlineGoogle Scholar
    • 85. Jubb RWPiva SBeinat LDacre JGishen PA one-year, randomised, placebo (saline) controlled clinical trial of 500-730 kDa sodium hyaluronate (Hyalgan) on the radiological change in osteoarthritis of the knee. Int J Clin Pract2003;57:467-74. [PMID: 12918884] MedlineGoogle Scholar
    • 86. Kahan ALleu PLSalin LProspective randomized study comparing the medicoeconomic benefits of Hylan GF-20 vs. conventional treatment in knee osteoarthritis. Joint Bone Spine2003;70:276-81. [PMID: 12951310] CrossrefMedlineGoogle Scholar
    • 87. Tetik SOnes KTetik CEfficacy of intra-articular Hylan G-F 20 on osteoarthritis of the knee. The Pain Clinic2003;15:459-66. CrossrefGoogle Scholar
    • 88. Tsai CLChang CCChen SCBeinat LPiva STreatment of knee osteoarthritis in Asian population with an intra-articular hyaluronan of MW500–730 KDa [Abstract P333]. Osteoarthritis Cartilage2003;11 Suppl A 119. Google Scholar
    • 89. Altman RDAkermark CBeaulieu ADSchnitzer TDurolane International Study GroupEfficacy and safety of a single intra-articular injection of non-animal stabilized hyaluronic acid (NASHA) in patients with osteoarthritis of the knee. Osteoarthritis Cartilage2004;12:642-9. [PMID: 15262244] CrossrefMedlineGoogle Scholar
    • 90. Day RBrooks PConaghan PGPetersen MMulticenter Trial GroupA double blind, randomized, multicenter, parallel group study of the effectiveness and tolerance of intraarticular hyaluronan in osteoarthritis of the knee. J Rheumatol2004;31:775-82. [PMID: 15088306] MedlineGoogle Scholar
    • 91. Groppa L, Golubciuc S, Vremis L, Dutca L, Sincari L. The efficacy of combined chondroprotective treatment in the osteoarthritis of the knee [Abstract 415]. Zurich, Switzerland: European League Against Rheumatism; 2004. Accessed at www.abstracts2view.com/eular/view.php?nu=EULAR04L1_2004FRI0415&terms on 27 February 2012. Google Scholar
    • 92. Pham TLe Henanff ARavaud PDieppe PPaolozzi LDougados MEvaluation of the symptomatic and structural efficacy of a new hyaluronic acid compound, NRD101, in comparison with diacerein and placebo in a 1 year randomised controlled study in symptomatic knee osteoarthritis. Ann Rheum Dis2004;63:1611-7. [PMID: 15331394] CrossrefMedlineGoogle Scholar
    • 93. Wu HBDu JYYang SHShao ZWXiong XQ[Evaluation on the effects of hyaluronan combined with different dosages of celecoxib for relieving pain and ankylosis induced by knee osteoarthritis]. Zhongguo Linchuang Kangfu2004;8:5491-3. Google Scholar
    • 94. Cubukçu DArdiç FKarabulut NTopuz OHylan G-F 20 efficacy on articular cartilage quality in patients with knee osteoarthritis: clinical and MRI assessment. Clin Rheumatol2005;24:336-41. [PMID: 15599642] CrossrefMedlineGoogle Scholar
    • 95. Huang MHYang RCLee CLChen TWWang MCPreliminary results of integrated therapy for patients with knee osteoarthritis. Arthritis Rheum2005;53:812-20. [PMID: 16342083] CrossrefMedlineGoogle Scholar
    • 96. Neustadt DCaldwell JBell MWade JGimbel JClinical effects of intraarticular injection of high molecular weight hyaluronan (Orthovisc) in osteoarthritis of the knee: a randomized, controlled, multicenter trial. J Rheumatol2005;32:1928-36. [PMID: 16206349] MedlineGoogle Scholar
    • 97. Sezgin MDemirel ACKaraca COrtancil OUlkar GBKanik Aet alDoes hyaluronan affect inflammatory cytokines in knee osteoarthritis? Rheumatol Int2005;25:264-9. [PMID: 14999424] CrossrefMedlineGoogle Scholar
    • 98. Kotevoglu NIyibozkurt PCHiz OToktas HKuran BA prospective randomised controlled clinical trial comparing the efficacy of different molecular weight hyaluronan solutions in the treatment of knee osteoarthritis. Rheumatol Int2006;26:325-30. [PMID: 15959784] CrossrefMedlineGoogle Scholar
    • 99. Petrella RJPetrella MA prospective, randomized, double-blind, placebo controlled study to evaluate the efficacy of intraarticular hyaluronic acid for osteoarthritis of the knee. J Rheumatol2006;33:951-6. [PMID: 16652426] MedlineGoogle Scholar
    • 100. Atay TAslan ABaydar MLCeylan BBaykal BKirdemir V[The efficacy of low- and high-molecular-weight hyaluronic acid applications after arthroscopic debridement in patients with osteoarthritis of the knee]. Acta Orthop Traumatol Turc2008;42:228-33. [PMID: 19060515] CrossrefMedlineGoogle Scholar
    • 101. Blanco FJFernández-Sueiro JLPinto-Tasende JAFernández-López JCRamallal MFreire Aet alIntra-articular hyaluronan treatment of patients with knee osteoarthritis waiting for replacement surgery. Open Arthritis J2008;1:1-7. CrossrefGoogle Scholar
    • 102. Heybeli NDoral MNAtay OALeblebicioğlu GUzümcügil A[Intra-articular sodium hyaluronate injections after arthroscopic debridement for osteoarthritis of the knee: a prospective, randomized, controlled study]. Acta Orthop Traumatol Turc2008;42:221-7. [PMID: 19060514] CrossrefMedlineGoogle Scholar
    • 103. Lundsgaard CDufour NFallentin EWinkel PGluud CIntra-articular sodium hyaluronate 2 mL versus physiological saline 20 mL versus physiological saline 2 mL for painful knee osteoarthritis: a randomized clinical trial. Scand J Rheumatol2008;37:142-50. [PMID: 18415773] CrossrefMedlineGoogle Scholar
    • 104. Petrella RJCogliano ADecaria JCombining two hyaluronic acids in osteoarthritis of the knee: a randomized, double-blind, placebo-controlled trial. Clin Rheumatol2008;27:975-81. [PMID: 18204873] CrossrefMedlineGoogle Scholar
    • 105. Altman RDRosen JEBloch DAHatoum HTKorner PA double-blind, randomized, saline-controlled study of the efficacy and safety of EUFLEXXA for treatment of painful osteoarthritis of the knee, with an open-label safety extension (the FLEXX trial). Semin Arthritis Rheum2009;39:1-9. [PMID: 19539353] CrossrefMedlineGoogle Scholar
    • 106. Baltzer AWMoser CJansen SAKrauspe RAutologous conditioned serum (Orthokine) is an effective treatment for knee osteoarthritis. Osteoarthritis Cartilage2009;17:152-60. [PMID: 18674932] CrossrefMedlineGoogle Scholar
    • 107. Baraf HSStrand VHosokawa HAkahane OLim SYaguchi MEffectiveness and safety of a single intraarticular injection of gel-200, a new cross-linked formulation of hyaluronic acid [HA] in the treatment of symptomatic osteoarthritis [OA] of the knee [Abstract 326]. Osteoarthritis Cartilage2009;17 Suppl 1 S174. CrossrefMedlineGoogle Scholar
    • 108. Diracoglu DVural MBaskent ADikici FAksoy CThe effect of viscosupplementation on neuromuscular control of the knee in patients with osteoarthritis. J Back Musculoskelet Rehabil2009;22:1-9. [PMID: 20023357] CrossrefMedlineGoogle Scholar
    • 109. Petrella RJDecaria JEWolfe DChesworth BShapiro SMontero-Odasso MThe effect of hyaluronic acid on gait in knee osteoarthritis patients: preliminary results for a randomized, double-blind, placebo controlled study [Abstract 375]. Ann Rheum Dis2009;68 Suppl 3 479. Google Scholar
    • 110. Chevalier XJerosch JGoupille Pvan Dijk NLuyten FPScott DLet alSingle, intra-articular treatment with 6 ml hylan G-F 20 in patients with symptomatic primary osteoarthritis of the knee: a randomised, multicentre, double-blind, placebo controlled trial. Ann Rheum Dis2010;69:113-9. [PMID: 19304567] CrossrefMedlineGoogle Scholar
    • 111. Jørgensen AStengaard-Pedersen KSimonsen OPfeiffer-Jensen MEriksen CBliddal Het alIntra-articular hyaluronan is without clinical effect in knee osteoarthritis: a multicentre, randomised, placebo-controlled, double-blind study of 337 patients followed for 1 year. Ann Rheum Dis2010;69:1097-102. [PMID: 20447955] CrossrefMedlineGoogle Scholar
    • 112. Kosuwon WSirichatiwapee WVisanuyotin TJeeravipoolvarn PLaupattarakasem WAn efficacy study on cartilage volume by MRI findings in patient with knee osteoarthritis between 25 mg of sodium hyaluronate (2.5 ml) to placebo [Abstract 370]. Ann Rheum Dis2010;69 Suppl 3 267. Google Scholar
    • 113. Kul-Panza EBerker NIs hyaluronate sodium effective in the management of knee osteoarthritis? A placebo-controlled double-blind study. Minerva Med2010;101:63-72. [PMID: 20467406] MedlineGoogle Scholar
    • 114. Pavelka KNiethard FUGiordan NA multicentre, international, double blind, randomized, placebo-controlled study to assess the efficacy and safety of 2 different regimens of HYADD4-G in knee osteoarthritis [Abstract 326]. Osteoarthritis Cartilage2010;18 Suppl 2 S144. CrossrefGoogle Scholar
    • 115. Sanofi-Aventis. TREAD-20: Trial of Hyalgan three injection-regimen for the treatment of knee pain due to osteoarthritis [clinical trial]. Accessed at http://clinicaltrials.gov/ct2/show/NCT00130468 on 21 February 2012. Google Scholar
    • 116. Huang TLChang CCLee CHChen SCLai CHTsai CLIntra-articular injections of sodium hyaluronate (Hyalgan®) in osteoarthritis of the knee. a randomized, controlled, double-blind, multicenter trial in the Asian population. BMC Musculoskelet Disord2011;12:221. [PMID: 21978211] CrossrefMedlineGoogle Scholar
    • 117. Navarro-Sarabia FCoronel PCollantes ENavarro FJde la Serna ARNaranjo Aet alAMELIA study groupA 40-month multicentre, randomised placebo-controlled study to assess the efficacy and carry-over effect of repeated intra-articular injections of hyaluronic acid in knee osteoarthritis: the AMELIA project. Ann Rheum Dis2011;70:1957-62. [PMID: 21852252] CrossrefMedlineGoogle Scholar
    • 118. Brandt KDBlock JAMichalski JPMoreland LWCaldwell JRLavin PTEfficacy and safety of intraarticular sodium hyaluronate in knee osteoarthritis. ORTHOVISC Study Group. Clin Orthop Relat Res2001;:130-43. [PMID: 11302304] CrossrefMedlineGoogle Scholar
    • 119. Kellgren JHLawrence JSRadiological assessment of osteo-arthrosis. Ann Rheum Dis1957;16:494-502. [PMID: 13498604] CrossrefMedlineGoogle Scholar
    • 120. Nüesch EJüni PCommentary: Which meta-analyses are conclusive? Int J Epidemiol2009;38:298-303. [PMID: 19074491] CrossrefMedlineGoogle Scholar
    • 121. Sterne JAGavaghan DEgger MPublication and related bias in meta-analysis: power of statistical tests and prevalence in the literature. J Clin Epidemiol2000;53:1119-29. [PMID: 11106885] CrossrefMedlineGoogle Scholar
    • 122. Pelletier JPHochberg MCdu Souich PKahan AMichel BAGlucosamine and osteoarthritis. Effect size is encouraging [Letter]. BMJ2010;341:c6328. [PMID: 21062884] CrossrefMedlineGoogle Scholar
    • 123. Ruyssen-Witrand ATubach FRavaud PSystematic review reveals heterogeneity in definition of a clinically relevant difference in pain. J Clin Epidemiol2011;64:463-70. [PMID: 21109400] CrossrefMedlineGoogle Scholar
    • 124. Nüesch EReichenbach STrelle SRutjes AWLiewald KSterchi Ret alThe importance of allocation concealment and patient blinding in osteoarthritis trials: a meta-epidemiologic study. Arthritis Rheum2009;61:1633-41. [PMID: 19950329] CrossrefMedlineGoogle Scholar
    • 125. Nüesch ETrelle SReichenbach SRutjes AWBürgi EScherer Met alThe effects of excluding patients from the analysis in randomised controlled trials: meta-epidemiological study. BMJ2009;339:b3244. [PMID: 19736281] CrossrefMedlineGoogle Scholar
    • 126. Modawal AFerrer MChoi HKCastle JAHyaluronic acid injections relieve knee pain. J Fam Pract2005;54:758-67. [PMID: 16144589] MedlineGoogle Scholar
    • 127. Wang CTLin JChang CJLin YTHou SMTherapeutic effects of hyaluronic acid on osteoarthritis of the knee. A meta-analysis of randomized controlled trials. J Bone Joint Surg Am2004;86-A:538-45. [PMID: 14996880] CrossrefMedlineGoogle Scholar
    • 128. Bellamy NCampbell JRobinson VGee TBourne RWells GViscosupplementation for the treatment of osteoarthritis of the knee. Cochrane Database Syst Rev2006;:CD005321. [PMID: 16625635] MedlineGoogle Scholar
    • 129. Arrich JPiribauer FMad PSchmid DKlaushofer KMüllner MIntra-articular hyaluronic acid for the treatment of osteoarthritis of the knee: systematic review and meta-analysis. CMAJ2005;172:1039-43. [PMID: 15824412] CrossrefMedlineGoogle Scholar
    • 130. Lo GHLaValley MMcAlindon TFelson DTIntra-articular hyaluronic acid in treatment of knee osteoarthritis: a meta-analysis. JAMA2003;290:3115-21. [PMID: 14679274] CrossrefMedlineGoogle Scholar
    • 131. Medina JMThomas ADenegar CRKnee osteoarthritis: should your patient opt for hyaluronic acid injection? J Fam Pract2006;55:669-75. [PMID: 16882439] MedlineGoogle Scholar
    • 132. Bannuru RRNatov NSDasi URSchmid CHMcAlindon TETherapeutic trajectory following intra-articular hyaluronic acid injection in knee osteoarthritis—meta-analysis. Osteoarthritis Cartilage2011;19:611-9. [PMID: 21443958] CrossrefMedlineGoogle Scholar